Champions Oncology

Access the Tumorgraft Database
  • Company
    • Company
    • Leadership
    • Events and News
    • Career Opportunities
    • Close
  • Solutions
    • Preclinical
    • Translational
    • Clinical
    • Strategic Partnering
    • Close
  • Products
    • Immuno-Oncology
    • Solid Tumor Oncology
    • Hematology Oncology 
Models
    • Custom Model Cohorts
    • Co-Clinical Trials
    • Patient Match Clinical Trials
    • Clinical 
Collaboration Network
    • Bioinformatics Analyses
    • Close
  • Resources
    • WebinarsWebinars
    • PostersPosters
    • PublicationsPublications
    • VideosVideos
    • Close
  • Personalized Oncology
  • Investors
    • StocksStock Information
    • Events and NewsEvents and News
    • Corporate GovernanceCorporate Governance
    • SEC filingsSEC Filings
    • Close
  • Contact Us
Stock Information
Events and News
Corporate Governance
SEC Filings
  1. Home
  2. Investors
  3. SEC Filings

SEC Filings

Download XBRL Files

10Q 2018-03-19
10Q 2017-12-15
10Q 2017-09-14
10K 2017-07-28
10Q 2017-03-17
10Q 2016-12-14
10Q 2016-09-14
10K 2016-07-29
10Q 2016-03-16
10Q 2015-12-15
10Q-2015-09-11
10K-2015-07-29
10Q-2015-03-17
10Q-2014-12-15
10Q-2014-09-12
10K-2014-07-28
10Q-2014-03-14
10Q-2013-12-13
10Q-2013-09-13
10K-2013-07-26
10Q-2013-03-13
10Q-2012-12-13
10Q-2012-09-12

For a complete list of SEC filings, please click here.

Champions Oncology

Helping to advance your oncology drug development portfolio with a superior end-to-end research and development service platform

Contact Us >

ACCESS THE TUMORGRAFT® DATABASE

A comprehensively annotated database of PDX models searchable through molecular characteristics, patient treatments, standard-of-care testing outcomes, or clinical features

Learn More >

Explore

  • Home About Products Solutions Investors
  • Webinars Posters Videos News Publications
  • Patients Leadership Events Resources Contact Us
  • Privacy
  • Legal Notice
  • Career Opportunities
  • Sitemap

© 2017 Copyright Champion Oncology, Inc. - All Rights Reserved.